Skip to main content
. 2022 Oct 4;58(1):30–38. doi: 10.1038/s41409-022-01833-0

Fig. 1. Outcome according to the HCT-CI.

Fig. 1

Non-Relapse Mortality (a), Cumulative Incidence of Relapse (b), and Overall Survival (c) after non-myeloablative hematopoietic stemm cell transplantation (NMA-HSCT) according to the three hematopoietic cell transplantation comorbidity index (HCT-CI) risk groups (n = 289).